Easton Pharmaceuticals (EAPH) Stock Statistics & Valuation Metrics

Easton Pharmaceuticals has a market cap or net worth of $1.34K. The enterprise value is -$23.19B.

Easton Pharmaceuticals has 1,344,933,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Easton Pharmaceuticals’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -1.97%.

The current PE Ratio of Easton Pharmaceuticals is ―. Easton Pharmaceuticals’s PEG ratio is 0.09.

In the last 12 months, Easton Pharmaceuticals had revenue of 0.00 and earned -189.00K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was 214.25K and capital expenditures -56.39K, giving a free cash flow of 157.86K billion.

Easton Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Easton Pharmaceuticals upcoming earnings date is Jun 13, 2019, TBA (Confirmed).

Easton Pharmaceuticals as a current ratio of 0.69, with Debt / Equity ratio of 35.93%

In the past 12 months, Easton Pharmaceuticals has paid 0.00 in taxes.

Easton Pharmaceuticals EV to EBITDA ratio is 2.78M, with an EV/FCF ratio of 111.83K.

Easton Pharmaceuticals has $0.00 in cash and marketable securities with $2.84M in debt, giving a net cash position of -$2.84M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Easton Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―